Efficacy and tolerance of mesalazine supposotories vs. hydrocortisone foam in proctitis

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 2, 1997, Pages 335-340

  Lucidarme, D ^a   Marteau, P ^b,c   Foucault, M ^b   Vautrin, B ^b   Filoche, B ^a  

^a Centre Hospitalier Saint Philibert GHICL   (France)

^b Ferring SAS   (France)

^c Hopital Saint Lazare   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; MESALAZINE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERANCE; ENDOSCOPY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; PROCTITIS; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; SIDE EFFECT; SUPPOSITORY;

EID: 0030997075     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.126297000.x     Document Type: Article

References (15)

1. Campieri M, Lanfranchi G, Bazzocchi G, et al. Treatment of ulcerative colitis with high-dose 5-aminosalicylic acid. Lancet 1981; ii: 270-1.
2. Danish 5-ASA Group. Topical 5-aminosalicylic acid vs. prednisolone in ulcerative proctosigmoiditis. A randomized, double-blind multicenter trial. Dig Dis Sci 1987; 32: 598-602.
3. Campieri M, Gionchetti P, Belluzzi A, et al. Efficacy of 5-aminosalicylic acid enemas vs. hydrocortisone enemas in ulcerative colitis. Dig Dis Sci 1987; 32 (December Suppl.): 67S-70S.
4. Lamers C, Meijer J, Engels L, et al. Comparative study of the topically acting glucocorticosteroid budesonide and 5-aminosalicylic acid enema therapy of proctitis and proctosigmoiditis. Gastroenterology 1991; 100: A223(Abstract).
5. Ngo Y, Rambaud JC. Lavement d'acide 5-aminosalicylique (Pentasa) vs. mousse d'acétate d'hydrocortisone (Proctocort) dans le traitement des poussées de rectite et rectosigmoïdite cryptogénétique. Gastroenterol Clin Biol 1992; 16: 558-63.
6. Lémann M, Galian A, Rutgeerts P, et al. Comparison of budesonide and 5-aminosalicylic acid enemas in active distal ulcerative colitis. Aliment Pharmacol Ther 1995; 9: 357-62.
7. Mulder CJ, Tytgat GN, Wiltink EH, Houtoff HJ. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double blind trial. Scand J Gastroenterol 1988; 23: 1005-8.
8. Campieri M, Gionchetti P, Belluzzi A, et al. 5-aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? J Clin Gastroenterol 1988; 10: 406-9.
9. Ruddell WSJ, Dickinson RJ, Dixon MF, Axon ATR. Treatment of distal ulcerative colitis (proctosigmoiditis) in relapse: comparison of hydrocortisone enemas and rectal hydrocortisone foam. Gut 1980; 21: 885-9.
10. Sommerville KW, Langman MJS, Kane SP, MacGilchrist AJ, Watkinson G, Salmon P. Effect of treatment on symptoms and quality of life in patients with ulcerative colitis: comparative trial of hydrocortisone acetate foam and prednisolone 21-phosphate enemas. Br Med J 1985; 291: 866.
11. Farup PG, Hovde O, Halvorsen FA, Raknerud N, Brodin U. Mesalazine suppositories vs. hydrocortisone foam in patients with distal ulcerative colitis. Scand J Gastroenterol 1995; 30: 164-70.
12. Lee FI, Jewell DP, Mani V, et al. A randomised trial comparing mesalazine and prednisolone foam enemas in patients with acute distal ulcerative colitis. Gut 1996; 38: 229-33.
13. Ngo Y, Gelinet JM, Ivanovic A, et al. Efficacité d'une application quotidienne d'un suppositoire de mesalazine (Pentasa) à libération progressive, dans le traitement des poussées de rectite ulcéro-hémorragique. Gastroenterol Clin Biol 1992; 16: 782-6.
14. Campieri M, Gionchetti P, Belluzzi A, et al. A controlled randomized trial comparing 5-aminosalicylic acid (5-ASA) 1 g once daily vs. 500 mg b.d. in treatment of active proctitis or distal proctosigmoiditis. Gastroenterology 1995; 108: A790 (Abstract).
15. Marteau P, Halphen, M. Etude comparative ouverte randomisée de l'efficacité et de la tolérance de lavements de 2 g d'acide 4-amino-salicylique (4-ASA) et de 1 g d'acide 5-aminosalicylique (5-ASA) dans les formes basses de rectocolite hémorragique. Gastroenterol Clin Biol 1995; 19: 31-5.